These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2007-000776-16 Development of Tumor Infiltrating Lymphocytes in Patients with Metastatic melanoma not-yet-due
Ongoing 2009-013406-13 First Line Therapy of Glioblastoma Multiforme with Surgical Resection, Irradiation Therapy, Temozolomide and Additional Tumour-Lysate Pulsed Dendritic Cell Vaccination. A Feasibility Phase II Study. not-yet-due
Ongoing 2011-001512-65 A Phase II study of metronomic and targeted anti-angiogenesis therapy for children with recurrent/progressive medulloblastoma not-yet-due
Completed, but no date Terminated 2011-004391-11 Treatment of metastatic renal cell carcinoma using interleukin-12 secreting dendritic cells. Phase I/II clinical trial. bad-data
Exempt 2014-003388-39 COMBINED ANTITUMOR THERAPY WITH EX VIVO MANIPULATED DENDRITIC CELLS PRODUCING INTERLEUKIN-12 IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH PROGRESSIVE, RECURRENT OR PRIMARILY METASTATIC HIGH-RISK TUM... not-yet-due
Ongoing 2015-002584-41 RECURENT NEUROBLASTOMA AND EWING´S SARCOMA: TREOSULPHAN BASED HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS PBSC SUPPORT not-yet-due
Not reported 2016-002177-35 The effect of gabapentin used as a preemptive to the emergence and development chronic neuropathic pain in patients after spinal cord trauma 2019-02-22 due-trials
Ongoing 2020-002060-31 An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care not-yet-due